相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting the oncogenic role of miRNA in human cancer using naturally occurring compounds
Stuart A. Rushworth
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I
Lin-Na Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
B. Venugopal et al.
CURRENT MEDICINAL CHEMISTRY (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
The VHL-dependent regulation of microRNAs in renal cancer
Calida S. Neal et al.
BMC MEDICINE (2010)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
Sreenivasulu Chintala et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Feedback regulators of hypoxia-inducible factors and their role in cancer biology
Anne-Theres Henze et al.
CELL CYCLE (2010)
Aberrant methylation and associated transcriptional mobilization of Alu elements contributes to genomic instability in hypoxia
Arnab Pal et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
Taking the measure of the methylome
Stephan Beck
NATURE BIOTECHNOLOGY (2010)
Epigenetic modifications and human disease
Anna Portela et al.
NATURE BIOTECHNOLOGY (2010)
Alterations in VHL as potential biomarkers in renal-cell carcinoma
Lucy Gossage et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation
Elizabeth Louie et al.
BREAST CANCER RESEARCH (2010)
Role of Hypoxia-Inducible Factors in Epigenetic Regulation via Histone Demethylases
Jun Yang et al.
HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY (2009)
Generation of an epigenetic signature by chronic hypoxia in prostate cells
Jenny A. Watson et al.
HUMAN MOLECULAR GENETICS (2009)
Human DNA methylomes at base resolution show widespread epigenomic differences
Ryan Lister et al.
NATURE (2009)
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
Akiko Doi et al.
NATURE GENETICS (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A. Northcott et al.
NATURE GENETICS (2009)
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
Rafael A. Irizarry et al.
NATURE GENETICS (2009)
Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells
S. H. Lee et al.
ONCOGENE (2009)
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
Xiaobo Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1
Elhadji M. Dioum et al.
SCIENCE (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
Patrick J. Pollard et al.
BIOCHEMICAL JOURNAL (2008)
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
Henk M. W. Verheul et al.
CLINICAL CANCER RESEARCH (2008)
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Carme Camps et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxia induces a novel signature of chromatin modifications and global repression of transcription
Amber Buescher Johnson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer
Yang Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
The complex language of chromatin regulation during transcription
Shelley L. Berger
NATURE (2007)
Specificity, duplex degradation and subcellular localization of antagomirs
Jan Krutzfeldt et al.
NUCLEIC ACIDS RESEARCH (2007)
Induction of DNA hypomethylation by tumor hypoxia
Siranoush Shahrzad et al.
EPIGENETICS (2007)
A microRNA signature of hypoxia
Ritu Kulshreshtha et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
Carla Hebert et al.
MOLECULAR CANCER (2007)
Gene expression patterns in the hypoxic murine placenta: A role in epigenesis?
Ciprian P. Gheorghe et al.
REPRODUCTIVE SCIENCES (2007)
MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia
Zhong Hua et al.
PLOS ONE (2006)
Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment
Alexander R. A. Anderson et al.
CELL (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
The diverse functions of MicroRNAs in animal development and disease
Wigard P. Kloosterman et al.
DEVELOPMENTAL CELL (2006)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-α
DM Fath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
J Weiler et al.
GENE THERAPY (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene expression profiling reveals a signaling role of glutathione in redox regulation
M Fratelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The HIF pathway in cancer
PH Maxwell
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death
T Abe et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
A Couvelard et al.
BRITISH JOURNAL OF CANCER (2005)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Carbonic anhydrase IX in early-stage non-small cell lung cancer
SJ Kim et al.
CLINICAL CANCER RESEARCH (2004)
The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2′-deoxycytidine
WG Alleman et al.
CLINICAL CANCER RESEARCH (2004)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
microRNAs: Tiny regulators with great potential
V Ambros
CELL (2001)
Dephosphorylated hypoxia-inducible factor 1α as a mediator of p53-dependent apoptosis during hypoxia
H Suzuki et al.
ONCOGENE (2001)
A novel amplicon at 9p23-24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB
ZQ Yang et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)